Literature DB >> 17185149

Patients with biallelic mutations in the chloride channel gene CLCNKB: long-term management and outcome.

Alberto Bettinelli1, Nicolò Borsa, Rosa Bellantuono, Marie-Louise Syrèn, Raffaele Calabrese, Alberto Edefonti, John Komninos, Marisa Santostefano, Luciano Beccaria, Ivana Pela, Mario G Bianchetti, Silvana Tedeschi.   

Abstract

BACKGROUND: Little information on the management and long-term follow-up of patients with biallelic mutations in the chloride channel gene CLCNKB is available.
METHODS: Long-term follow-up was evaluated from 5.0 to 24 years (median, 14 years) after diagnosis in 13 patients with homozygous (n = 10) or compound heterozygous (n = 3) mutations.
RESULTS: Medical treatment at last follow-up control included supplementation with potassium in 12 patients and sodium in 2 patients and medical treatment with indomethacin in 9 patients. At the end of follow-up, body height was 2.0 standard deviation score or less in 6 patients; 2 of these patients had growth hormone deficiency. Body weight (<or=2.0 standard deviation score in 6 patients) significantly increased (P < 0.05) at the end of follow-up in comparison to values at diagnosis. Nonpostural persistent proteinuria was present in 6 patients, and 4 patients had a glomerular filtration rate less than 75 mL/min/1.73 m(2) (<1.25 mL/s).
CONCLUSION: These data show that some patients with biallelic mutations in the chloride channel gene CLCNKB tend to present with pathological proteinuria and impaired kidney function after a median follow-up of 14 years, and growth retardation is common and sometimes related to growth hormone deficiency in these patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17185149     DOI: 10.1053/j.ajkd.2006.10.001

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  25 in total

1.  Chronic renal failure in a boy with classic Bartter's syndrome due to a novel mutation in CLCNKB coding for the chloride channel.

Authors:  Chien-Ming Lin; Jeng-Daw Tsai; Yi-Fen Lo; Ming-Tso Yan; Sung-Sen Yang; Shih-Hua Lin
Journal:  Eur J Pediatr       Date:  2008-12-03       Impact factor: 3.183

2.  Antenatal Bartter syndrome presenting with vomiting and constipation mimicking subacute intestinal obstruction in a 20-day-old neonate.

Authors:  Ibtihal Siddiq Abdelgadir; Fawzia Elgharbawy; Khalil Mohamad Salameh; Baha Eldin Juma
Journal:  BMJ Case Rep       Date:  2017-11-14

3.  Phosphate homeostasis in Bartter syndrome: a case-control study.

Authors:  Alberto Bettinelli; Cristina Viganò; Maria Cristina Provero; Francesco Barretta; Alessandra Albisetti; Silvana Tedeschi; Barbara Scicchitano; Mario G Bianchetti
Journal:  Pediatr Nephrol       Date:  2014-06-06       Impact factor: 3.714

4.  Functional severity of CLCNKB mutations correlates with phenotypes in patients with classic Bartter's syndrome.

Authors:  Chih-Jen Cheng; Yi-Fen Lo; Jen-Chi Chen; Chou-Long Huang; Shih-Hua Lin
Journal:  J Physiol       Date:  2017-06-27       Impact factor: 5.182

5.  Early appearance of hypokalemia in Gitelman syndrome.

Authors:  Fabiana Tammaro; Alberto Bettinelli; Donatella Cattarelli; Alessandra Cavazza; Carla Colombo; Marie-Louise Syrén; Silvana Tedeschi; Mario G Bianchetti
Journal:  Pediatr Nephrol       Date:  2010-06-16       Impact factor: 3.714

6.  Clinical and Genetic Spectrum of Bartter Syndrome Type 3.

Authors:  Elsa Seys; Olga Andrini; Mathilde Keck; Lamisse Mansour-Hendili; Pierre-Yves Courand; Christophe Simian; Georges Deschenes; Theresa Kwon; Aurélia Bertholet-Thomas; Guillaume Bobrie; Jean Sébastien Borde; Guylhène Bourdat-Michel; Stéphane Decramer; Mathilde Cailliez; Pauline Krug; Paul Cozette; Jean Daniel Delbet; Laurence Dubourg; Dominique Chaveau; Marc Fila; Noémie Jourde-Chiche; Bertrand Knebelmann; Marie-Pierre Lavocat; Sandrine Lemoine; Djamal Djeddi; Brigitte Llanas; Ferielle Louillet; Elodie Merieau; Maria Mileva; Luisa Mota-Vieira; Christiane Mousson; François Nobili; Robert Novo; Gwenaëlle Roussey-Kesler; Isabelle Vrillon; Stephen B Walsh; Jacques Teulon; Anne Blanchard; Rosa Vargas-Poussou
Journal:  J Am Soc Nephrol       Date:  2017-04-05       Impact factor: 10.121

7.  A patient with Bartter syndrome accompanying severe growth hormone deficiency and focal segmental glomerulosclerosis.

Authors:  Ipek Akil; Serkan Ozen; Ali Riza Kandiloglu; Betul Ersoy
Journal:  Clin Exp Nephrol       Date:  2010-02-04       Impact factor: 2.801

Review 8.  Longitudinal growth in chronic hypokalemic disorders.

Authors:  Helena Gil-Peña; Natalia Mejia; Oscar Alvarez-Garcia; Vanessa Loredo; Fernando Santos
Journal:  Pediatr Nephrol       Date:  2009-11-10       Impact factor: 3.714

Review 9.  Personalized Intervention in Monogenic Stone Formers.

Authors:  Lucas J Policastro; Subodh J Saggi; David S Goldfarb; Jeffrey P Weiss
Journal:  J Urol       Date:  2017-10-20       Impact factor: 7.450

10.  Carboxyl-terminal Truncations of ClC-Kb Abolish Channel Activation by Barttin Via Modified Common Gating and Trafficking.

Authors:  Gabriel Stölting; Stefanie Bungert-Plümke; Arne Franzen; Christoph Fahlke
Journal:  J Biol Chem       Date:  2015-10-09       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.